936617-31-1

Basic information

• Product Name: 12-{2-[12-(3-Aminooxalyl-4-tert-butoxycarbonylmethoxy-2-methyl-indol-1-yl)-dodecyloxy]-phenoxy}-dodecanoic acid benzyl ester
• Synonyms: 12-{2-[12-(3-Aminooxalyl-4-tert-butoxycarbonylmethoxy-2-methyl-indol-1-yl)-dodecyloxy]-phenoxy}-dodecanoic acid benzyl ester
• CAS NO: 936617-31-1
• Molecular Weight: 897.205
• Mol File: 936617-31-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 12-{2-[12-(3-Aminooxalyl-4-tert-butoxycarbonylmethoxy-2-methyl-indol-1-yl)-dodecyloxy]-phenoxy}-dodecanoic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 12-{2-[12-(3-Aminooxalyl-4-tert-butoxycarbonylmethoxy-2-methyl-indol-1-yl)-dodecyloxy]-phenoxy}-dodecanoic acid benzyl ester(936617-31-1)
• EPA Substance Registry System: 12-{2-[12-(3-Aminooxalyl-4-tert-butoxycarbonylmethoxy-2-methyl-indol-1-yl)-dodecyloxy]-phenoxy}-dodecanoic acid benzyl ester(936617-31-1)

Safety Data

• Hazardous Substances Data: 936617-31-1(Hazardous Substances Data)

Upstream product

• 936616-94-3 tert-butyl 2-(3-(2-amino-2-oxoacetyl)-1-(12-bromododecyl)-2-methyl-1H-indol-4-yloxy)acetate 
• 120-80-9 benzene-1,2-diol 
• 178213-19-9 benzyl 12-bromododecanoate 

Relevant articles and documents

PHOSPHOLIPASE INHIBITORS, INCLUDING MULTI-VALENT PHOSPHOLIPASE INHIBITORS, AND USE THEREOF, INCLUDING AS LUMEN-LOCALIZED PHOSPHOLIPASE INHIBITORS

The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.